product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
eIF4G2/p97 (D1A10) Rabbit mAb
catalog :
3468
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D1A10
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 4
Reference
Kreckel J, Anany M, Siegmund D, Wajant H. TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling. Front Immunol. 2019;10:2024 pubmed publisher
Lee I, Lim J, Cho H, Kim E, Kim Y, Oh H, et al. MST1 Negatively Regulates TNFα-Induced NF-κB Signaling through Modulating LUBAC Activity. Mol Cell. 2019;73:1138-1149.e6 pubmed publisher
Klein T, Fung S, Renner F, Blank M, Dufour A, Kang S, et al. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling. Nat Commun. 2015;6:8777 pubmed publisher
Wu X, Fukushima H, North B, Nagaoka Y, Nagashima K, Deng F, et al. SCF?-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination. Oncotarget. 2014;5:4211-21 pubmed
product information
SKU :
3468S
Product-Name :
eIF4G2/p97 (D1A10) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R
Applications :
Immunoprecipitation
Product-Category :
Translational Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
97
Host :
Rabbit
Target :
eIF4G2/DAP5
Primary-Protein :
eIF4G2
Alt-Names :
AAG1,DAP-5,DAP5,Death-associated protein 5,EIF4G2,Eukaryotic translation initiation factor 4 gamma 2,FLJ41344,IF4G2,NAT1,aging-associated protein 1,eIF-4-gamma 2,eIF-4G 2,eIF4G 2,eukaryotic translation initiation factor 4 gamma, 2,eukaryotic translation initiation factor 4G-like 1,p97
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.